Health ❯ Healthcare ❯ Medicine

Pharmacology

Diabetes Acetaminophen GLP-1 Receptor Agonists Diabetes Medications Diabetes Treatment Weight Loss Medications Pregnancy Child Development Antibody-Drug Conjugates Drug Approval

Nordic Study Links SGLT2 Diabetes Drugs to Increased Ketoacidosis Risk

The pooled registry analysis identifies patient features tied to higher risk and urges clearer guidance on pausing treatment during acute illness.

Study Finds Small Increase in Optic‑Nerve Injury With GLP‑1 Diabetes Drugs

TROP2 Pinpoints and Permits Targeted Attack on Metastasis‑Driving Colorectal Cells

Dapagliflozin Cuts Heart-Failure Hospitalizations by About 80% in People With Cardiomyopathy Genes

Erleada Plus Hormone Therapy Cuts Recurrence and Death in High‑Risk Localized Prostate Cancer

Metformin Triggers Exercise-Linked Signal in Prostate Cancer Patients

Lancet Review Finds No Link Between Prenatal Tylenol Use and Autism, ADHD or Intellectual Disability

Largest Review Finds No Link Between Prenatal Acetaminophen and Autism or ADHD

Lancet Meta-Analysis Finds No Neurodevelopmental Risk From Paracetamol in Pregnancy

Statins Cut Deaths and Major Cardiac Events Across Risk Levels in Type 2 Diabetes

Metformin Blunts Exercise Benefits in Rutgers Randomized Trial

FDA Approves Lilly’s Inluriyo for ESR1‑Mutated Advanced Breast Cancer

Low-Dose Aspirin Linked to Lower Cancer Risk in Seniors, With Strongest Signal in CHIP

Canadian Obstetricians Reaffirm Tylenol’s Pregnancy Safety as Debate Over Autism Link Intensifies

Kenvue Urges HHS to Reject Autism Link to Prenatal Tylenol in Private Meeting

JAMA Studies Find Rare Optic-Nerve Risks With Semaglutide and Tirzepatide

Glipizide Linked to 13% Higher Cardiovascular Risk Than DPP-4 Inhibitors

Meta-Analysis Finds Predictable Weight Rebound After Stopping Anti-Obesity Drugs

Study Confirms Triptan Use in Pregnancy Does Not Increase Neurodevelopmental Risks

Gabapentin Shows Potential to Extend Survival in Glioblastoma Patients